Dpyd Genotyping
DPYD Genotyping is a pharmacogenetic testing method that identifies genetic variants in the *DPYD* gene responsible for dihydropyrimidine dehydrogenase enzyme activity, enabling the prediction of individual susceptibility to severe toxicity from fluoropyrimidine chemotherapy.
147
Publications
8.2K
Citations
1.2K
Authors
454
Institutions
Publications per year
2017–2026
76
Parents
147
Matthias Schwab, Ulrich M. Zanger, Claudia Marx et al. · Journal of Clinical Oncology · 2008 · 394 citations · Full text
Kelly E. Caudle, Caroline F. Thorn, Teri E. Klein et al. · Clinical Pharmacology & Therapeutics · 2013 · 322 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 147
1.2K
14
h-index
13
h-index
12
h-index
11
h-index
10
h-index
1–5 of 1.2K
454
The Netherlands Cancer Institute
Amsterdam, The Netherlands
12 h-index
80 publications
11K citations
Utrecht University
Utrecht, The Netherlands
12 h-index
46 publications
8.6K citations

University of Amsterdam
Amsterdam, The Netherlands
12 h-index
28 publications
2.1K citations
Oncode Institute
Utrecht, Netherlands
11 h-index
50 publications
4.9K citations

Leiden University Medical Center
Leiden, The Netherlands
10 h-index
48 publications
6.4K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
10 h-index
65 publications
2.9K citations
Inserm
Paris, France
9 h-index
32 publications
1.9K citations

University Hospital of Bern
Bern, Switzerland
8 h-index
28 publications
1.8K citations
1–8 of 454
9 publications · 348 citations
9
h-index
Repository · 8 publications · 329 citations
8
h-index
8 publications · 173 citations
8
h-index
BJC · 6 publications · 421 citations
6
h-index
5 publications · 523 citations
5
h-index
1–5